Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 117.84 | 91.68 | 73.17 | 53.58 |
Depreciation/ Depletion | 17.07 | 15.50 | 15.66 | 16.47 |
Non- Cash Items | -4.15 | -2.19 | -2.12 | 0.08 |
Changesin Working Capital | -36.40 | -14.18 | -21.96 | -11.86 |
Cashfrom Operating Activities | 94.36 | 90.81 | 64.75 | 58.27 |
Capital Expenditures | -69.23 | -32.73 | -23.95 | -8.51 |
Other Investing Cash Flow Items Total | -9.92 | -73.08 | -10.71 | 0.55 |
Cashfrom Investing Activities | -79.15 | -105.81 | -34.66 | -7.96 |
Financing Cash Flow Items | -0.45 | -0.31 | -0.52 | -0.79 |
Total Cash Dividends Paid | -19.85 | -15.88 | -11.91 | - |
Issuance( Retirement)of Debt Net | -0.01 | -0.93 | -1.08 | -9.70 |
Cashfrom Financing Activities | -20.31 | -17.12 | -13.51 | -10.49 |
Net Changein Cash | -5.10 | -32.12 | 16.58 | 39.82 |
Cash Interest Paid | 0.45 | 0.31 | 0.52 | 0.79 |
Cash Taxes Paid | 29.31 | 25.23 | 18.85 | 8.33 |
RPG Life Sciences Dividend RPG Life Sciences Bonus RPG Life Sciences News RPG Life Sciences AGM RPG Life Sciences Rights RPG Life Sciences Splits RPG Life Sciences Board Meetings RPG Life Sciences Key Metrics RPG Life Sciences Shareholdings RPG Life Sciences Profit Loss RPG Life Sciences Balance Sheet RPG Life Sciences Q1 Results RPG Life Sciences Q2 Results RPG Life Sciences Q3 Results RPG Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks